Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1940 Jan;19(1):123–127. doi: 10.1172/JCI101106

THE OCCURRENCE OF METHEMOGLOBINEMIA DURING SULFANILAMIDE THERAPY

Charles L Fox Jr 1,2,1, James E Cline 1,2
PMCID: PMC434948  PMID: 16694720

Full text

PDF
125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chesley L. C. CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT. J Clin Invest. 1938 Jul;17(4):445–447. doi: 10.1172/JCI100971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Harris J. S., Michel H. O. THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY. J Clin Invest. 1939 Sep;18(5):507–519. doi: 10.1172/JCI101064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Wendel W. B. THE CONTROL OF METHEMOGLOBINEMIA WITH METHYLENE BLUE. J Clin Invest. 1939 Mar;18(2):179–185. doi: 10.1172/JCI101033. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES